PARLIAMENTARY WRITTEN QUESTION
Drugs: Licensing (11 December 2014)
Question Asked
To ask the Secretary of State for Health, how many breast cancer clinicians his Department met directly when developing its position on the Off-patent Drugs Bill.
Asked by:
Kerry McCarthy (Labour)
Asked by:
Kerry McCarthy (Labour)
Answer
In developing our response to the Bill, we have taken advice from a number of cancer clinicians including breast cancer specialists and from officials at the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency, and taken account of views expressed by other stakeholder organisations.
Answered by:
George Freeman (Conservative)
17 December 2014
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.